Motoko Unoki

Prof. Motoko Unoki

School of Veterinary Medicine, Azabu University, Sagamihara, Kanagawa, Japan
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2010 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
SHShinya Hayami
Shinya Hayami
JKJohn D. Kelly
John D. Kelly
HCHyun‐Soo Cho
Hyun‐Soo Cho
MYMasanori Yoshimatsu
Masanori Yoshimatsu
Motoko UnokiMotoko Unoki
Motoko Unoki
Ryuji HamamotoRyuji Hamamoto
Ryuji Hamamoto
A number of histone demethylases have been identified and biochemically characterized, but the pathological roles of their dysfunction in human disease like cancer have not been well understood. Here, we demonstrate important roles of lysine‐specific demethylase 1 (LSD1) in human carcinogenesis. Expression levels of LSD1 are significantly elevated in human bladder carcinomas compared with nonneoplastic bladder tissues (p < 0.0001). cDNA microarray analysis also revealed its transactivation in lung and colorectal carcinomas. LSD1‐specific small interfering RNAs significantly knocked down its expression and resulted in suppression of proliferation of various bladder and lung cancer cell lines. Concordantly, introduction of exogenous LSD1 expression promoted cell cycle progression of human embryonic kidney fibroblast cells. Expression profile analysis showed that LSD1 could affect the expression of genes involved in various chromatin‐modifying pathways such as chromatin remodeling at centromere, centromeric heterochromatin formation and chromatin assembly, indicating its essential roles in carcinogenesis through chromatin modification.


13 September 2004 in Oncogene
Verified
Journal Article
Closed access
Motoko UnokiMotoko Unoki
Motoko Unoki
TNToshihiko Nishidate
Toshihiko Nishidate
YNYusuke Nakamura
Yusuke Nakamura

27 November 2010 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
MYMasanori Yoshimatsu
Masanori Yoshimatsu
GTGouji Toyokawa
Gouji Toyokawa
SHShinya Hayami
Shinya Hayami
Motoko UnokiMotoko Unoki
Motoko Unoki
TTTatsuhiko Tsunoda
Tatsuhiko Tsunoda
Ryuji HamamotoRyuji Hamamoto
Ryuji Hamamoto
Protein arginine methylation is a novel post‐translational modification regulating a diversity of cellular processes, including histone functions, but the roles of protein arginine methyltransferases (PRMTs) in human cancer are not well investigated. To address this issue, we first examined expression levels of genes belonging to the PRMT family and found significantly higher expression of PRMT1 and PRMT6, both of which are Type I PRMTs, in cancer cells of various tissues than in non‐neoplastic cells. Abrogation of the expression of these genes with specific siRNAs significantly suppressed growth of bladder and lung cancer cells. Expression profile analysis using the cells transfected with the siRNAs indicated that PRMT1 and PRMT6 interplay in multiple pathways, supporting regulatory roles in the cell cycle, RNA processing and also DNA replication that are fundamentally important for cancer cell proliferation. Furthermore, we demonstrated that serum asymmetric dimethylarginine (ADMA) levels of a number of cancer cases are significantly higher than those of nontumor control cases. In summary, our results suggest that dysregulation of PRMT1 and PRMT6 can be involved in human carcinogenesis and that these Type I arginine methyltransferases are good therapeutic targets for various types of cancer.

28 July 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
PTPeter E. Thijssen
Peter E. Thijssen
YIYuya Ito
Yuya Ito
GGGiacomo Grillo
Giacomo Grillo
JWJun Wang
Jun Wang
GVGuillaume Velasco
Guillaume Velasco
HSHiroyuki Sasaki
Hiroyuki Sasaki
The life-threatening Immunodeficiency, Centromeric Instability and Facial Anomalies (ICF) syndrome is a genetically heterogeneous autosomal recessive disorder. Twenty percent of patients cannot be explained by mutations in the known ICF genes DNA methyltransferase 3B or zinc-finger and BTB domain containing 24. Here we report mutations in the cell division cycle associated 7 and the helicase, lymphoid-specific genes in 10 unexplained ICF cases. Our data highlight the genetic heterogeneity of ICF syndrome; however, they provide evidence that all genes act in common or converging pathways leading to the ICF phenotype.

25 July 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
KAKyohei Arita
Kyohei Arita
SIShin Isogai
Shin Isogai
TOTakashi Oda
Takashi Oda
Motoko UnokiMotoko Unoki
Motoko Unoki
KSKazuya Sugita
Kazuya Sugita
MSMasahiro Shirakawa
Masahiro Shirakawa
Multiple covalent modifications on a histone tail are often recognized by linked histone reader modules. UHRF1 [ubiquitin-like, containing plant homeodomain (PHD) and really interesting new gene (RING) finger domains 1], an essential factor for maintenance of DNA methylation, contains linked two-histone reader modules, a tandem Tudor domain and a PHD finger, tethered by a 17-aa linker, and has been implicated to link histone modifications and DNA methylation. Here, we present the crystal structure of the linked histone reader modules of UHRF1 in complex with the amino-terminal tail of histone H3. Our structural and biochemical data provide the basis for combinatorial readout of unmodified Arg-2 (H3-R2) and methylated Lys-9 (H3-K9) by the tandem tudor domain and the PHD finger. The structure reveals that the intermodule linker plays an essential role in the formation of a histone H3–binding hole between the reader modules by making extended contacts with the tandem tudor domain. The histone H3 tail fits into the hole by adopting a compact fold harboring a central helix, which allows both of the reader modules to simultaneously recognize the modification states at H3-R2 and H3-K9. Our data also suggest that phosphorylation of a linker residue can modulate the relative position of the reader modules, thereby altering the histone H3–binding mode. This finding implies that the linker region plays a role as a functional switch of UHRF1 involved in multiple regulatory pathways such as maintenance of DNA methylation and transcriptional repression.